CMS merges coverage for magnetic resonance angiography and MRI
This article was originally published in The Gray Sheet
Executive Summary
Medicare agency finalizes its decision memo June 3 on magnetic resonance angiography, a specific application of magnetic resonance imaging used for blood flow determination, consolidating provisions under a single national coverage determination. The decision eliminates certain non-coverage language for MRA, but leaves most coverage decisions to the discretion of local contractors. CMS opened the coverage determination last October (1"The Gray Sheet" Oct. 12, 2009)
You may also be interested in...
CMS opens coverage analysis on MR angiography
Medicare agency opens 30-day comment period on Oct. 7 for an internally-generated national coverage analysis of magnetic resonance angiography (MRA), a magnetic resonance imaging procedure for visualization of blood flow and diseased vessels. CMS recently lifted the national non-coverage status for MRI for blood flow, leaving decisions on MRA in the hands of local Medicare contractors. The agency seeks comments on the long- and short-term clinical outcomes of MRA for indications that remain non-covered in the Medicare population. Comments are due Nov. 6, and CMS plans to issue a final decision by July 6, 2010
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.